Prothrombotic microparticles and risk of portal vein thrombosis in patients with HCV-related liver cirrhosis who underwent DAA antiviral therapy. Issue 1 (16th February 2017) - Zanetto, A.; Campello, E.; Radu, C.M.; Shalaby, S.; Franceschet, E.; Frigo, A.M.; Ferrarese, A.; Bortoluzzi, I.; Gambato, M.; Germani, G.; Senzolo, M.; Floreani, A.; et al.